HOME /

News

David Corey is a Q-FASTR Award Recipient for 2023-2024

September 13, 2023
2023-2024 Quadrangle Fund for Advancing and Seeding Translational Research (Q-FASTR) Award

Gene editing to treat hereditary deafness
David Corey (Harvard Medical School) and Benjamin Kleinstiver (Harvard Medical School/Massachusetts General Hospital)  

Each of these internal awards is designed to provide Harvard Medical School faculty with funding to pursue innovative research that is challenging to support via other funding channels.

Usher Syndrome

April 14, 2022
We will present work on gene therapy for Usher syndrome at three meetings in May: Association for Research in Vision and Ophthalmology, American Society for Gene and Cell Therapy, and Molecular Biology of Hearing and Deafness.

TMC1 Paper In Review

April 11, 2022
Our paper on the molecular basis of TMC1 transduction channel gating, currently posted on bioRxiv, is submitted and in review at Science Advances.

Welcome 2 new graduate students

April 1, 2022
We are thrilled to welcome two new graduate students to the laboratory: Corena Loeb and Ginnie Hu. Both are second-year students in the Harvard PhD program in Speech and Hearing Biosciences and Technology.

NIH grant proposal

March 31, 2022
Our collaborative NIH grant proposal on miniPCDH15 therapy for Usher 1F, with Artur Indzhykulian (Mass Eye and Ear) and Marcos Sotomayor (Ohio State), got a great score and is slated for funding.

Eric Mulhall postdoc appointment

October 6, 2021
Eric Mulhall, a recent PhD student, is now a postdoc with Ardem Patapoutian and joined that laboratory just in time to help Ardem celebrate his Nobel Prize.